000262718 001__ 262718
000262718 005__ 20190812204755.0
000262718 022__ $$a1043-0342
000262718 022__ $$a1557-7422
000262718 02470 $$2isi$$a000453707700305
000262718 037__ $$aCONF
000262718 245__ $$aTowards high throughput drug screening for human retina organoids
000262718 260__ $$c2018$$aNew Rochelle$$bMARY ANN LIEBERT, INC
000262718 269__ $$a2018-12-01
000262718 336__ $$aConference Papers
000262718 650__ $$aBiotechnology & Applied Microbiology
000262718 650__ $$aGenetics & Heredity
000262718 650__ $$aMedicine, Research & Experimental
000262718 650__ $$aBiotechnology & Applied Microbiology
000262718 650__ $$aGenetics & Heredity
000262718 650__ $$aResearch & Experimental Medicine
000262718 700__ $$aArsenijevic, Y.
000262718 700__ $$aDecembrini, S.
000262718 700__ $$aMoser, R.
000262718 700__ $$aHoehnel, S.
000262718 700__ $$g175345$$0246507$$aBrandenberg, N.
000262718 700__ $$aGamm, D.
000262718 700__ $$ade Leone, V. Ponce
000262718 700__ $$aLutolf, M.
000262718 7112_ $$aConference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy$$dOct 16-19, 2018$$cLausanne, SWITZERLAND
000262718 773__ $$k12$$j29$$qA96-A96$$tHuman Gene Therapy
000262718 909CO $$pconf$$ooai:infoscience.epfl.ch:262718
000262718 961__ $$afantin.reichler@epfl.ch
000262718 973__ $$aEPFL$$sPUBLISHED$$rREVIEWED
000262718 980__ $$aCONF
000262718 980__ $$aWoS
000262718 981__ $$aoverwrite
000262718 999C0 $$0252143$$mmatthias.lutolf@epfl.ch$$mjulia.prebandier@epfl.ch$$zBlumer, Eliane$$pUPLUT$$xU11736